Sort   by:  
 Page size 
The metabolic adaptations observed in cancer are widely recognized, yet the precise mechanisms of how these metabolic adjustments support tumor growth remain unclear. This study explores the impact of guanine nucleotide metabolism on cancer progression in ALK-driven lung cancer. We showed that GUK1 ...
ORGANISM(S): Homo sapiens (Human) 
2025-02-03 | PXD049284 | Pride
Little is known about metabolic vulnerabilities in oncogene-driven lung cancer. Here, we performed a phosphoproteomic screen in anaplastic lymphoma kinase (ALK)-rearranged (“ALK+”) patient-derived cell lines and identified guanylate kinase 1 (GUK1), a GDP-synthesizing enzyme, as a novel target of AL...
ORGANISM(S): Homo sapiens (Human) 
2025-01-29 | PXD053405 | Pride
Sort   by:  
 Page size